- Work +90 212 366 4700
- Fax +90 212 290 2355
AMGEN ACQUISITION OF 95.6 % OF SHARES IN MN
Amgen (NASDAQ:AMGN), the world’s largest biotechnology company, signed an agreement on 24 April 2012 for acquisition of approximately 94% of Mustafa Nevzat İlaç Sanayii A.Ş., which is one of the largest generic injectable manufacturers in Turkey, for an amount that values target company around USD 700m.
Following the transaction Amgen will contribute to enhancing the future expansions, particularly in view of the bio-similars.
The transaction is subject to Competition Board approval.
Paksoy is pleased to announce that Mr. Serdar Paksoy (senior partner), Ms. Elvan Aziz (partner), Mr. Togan Turan (competition partner) and Mrs. Stephanie Beghe Sonmez (Senior International Counsel) represented Amgen in this transaction.
For more information please visit www.paksoy.av.tr